Medidata Solutions says 'on track' to achieve financial outlook Medidata Solutions said in its earnings release, "We are off to a good start to the year and on track to achieving the financial outlook we provided earlier in the year. We continue to make disciplined investments to maximize our long-term opportunity to drive platform adoption while advancing our growth trajectory." Shares of Medidata are down 15% to $45 in pre-market trading following the company's Q1 results.
Medidata Solutions COO appointment positive, says JPMorgan JPMorgan views Medidata's addition of Michael Capone in the newly created role of COO as a positive, as Capone should be able to help the company scale and should free up the company's CEO and President to focus on strategy and big deals. The firm maintains its Overweight rating on the stock.